Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 40, 2011 - Issue 1
Submit an article Journal homepage
348
Views
24
CrossRef citations to date
0
Altmetric
Case Report

Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature

JT Gran Departments of RheumatologyCorrespondence[email protected]
,
Ø Midtvedt Departments of Rheumatology
,
S Haug Dermatology
&
P Aukrust Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway
Pages 74-79 | Accepted 13 May 2010, Published online: 11 Oct 2010

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Kyle Tegtmeyer, Giancarlo Atassi, Jeffrey Zhao, Nolan J. Maloney & Peter A. Lio. (2022) Off-Label studies on anakinra in dermatology: a review. Journal of Dermatological Treatment 33:1, pages 73-86.
Read now
Astrid Sönnichsen, Ieva Saulite, Johanna Mangana, Katrin Kerl, Tarun Mehra, Ignatova Desislava, Yun-Tsan Chang, Ulf Petrausch, Peter Schmid-Grendelmeier, Wolfram Hoetzenecker, Antonio Cozzio & Emmanuella Guenova. (2016) Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome. Journal of Dermatological Treatment 27:5, pages 436-438.
Read now
Dan Lipsker & Cédric Lenormand. (2014) Management of Schnitzler’s syndrome. Expert Opinion on Orphan Drugs 2:9, pages 947-955.
Read now

Articles from other publishers (21)

Elle Levit, Janice LeonMatthew R. Lincoln. (2023) Pearls & Oy-sters: Homozygous Complement Factor I Deficiency Presenting as Fulminant Relapsing Complement-Mediated CNS Vasculitis. Neurology 101:2.
Crossref
Dennis D. Arnold, Ayla Yalamanoglu & Onur Boyman. (2022) Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders. Frontiers in Immunology 13.
Crossref
E. L. Nasonov & M. Yu. Samsonov. (2022) The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist). Rheumatology Science and Practice 60:3, pages 280-298.
Crossref
Fawad Aslam, Julia E. Wiedmeier & David J. DiCaudo. (2021) A Man With Recurrent Fever, Episodic Rash, and Pain. Arthritis Care & Research 73:8, pages 1106-1113.
Crossref
Silvia Stefania, Ripalta Colia, Rotondo Cinzia, Addolorata Corrado & Francesco Paolo Cantatore. (2021) Off-label use of anti-IL-1 drugs in rheumatic diseases. International Journal of Immunopathology and Pharmacology 35, pages 205873842110065.
Crossref
S O Salugina, V R Gorodetsky, E S Fedorov, N E Lopatina & M D Evsikova. (2017) Schnitzler syndrome: A review of literature, the authors’ observation, and experience with the interleukin-1 inhibitor canakinumab. Terapevticheskii arkhiv 89:11, pages 111-115.
Crossref
Linda Rossi-Semerano, Bruno Fautrel, Daniel Wendling, Eric Hachulla, Caroline Galeotti, Luca Semerano, Isabelle Touitou & Isabelle Koné-Paut. (2015) Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey. Orphanet Journal of Rare Diseases 10:1, pages 19.
Crossref
Achille Aouba, Claire Pressiat, Maria Pricopi, Sophie Georgin-Lavialle, François Boue, Maria-Angela Lievre-Castilla, Anne Marfaing-Koka, Sophie Prevot & Audrey Decottignies. (2015) Complete Remission of Schnitzler Syndrome and Waldenström Macroglobulinemia under Rituximab-Cyclophosphamide-Dexamethasone. Dermatology 230:1, pages 18-22.
Crossref
Y. Jamilloux, P. Sève & T. Henry. (2014) Les inflammasomes et les maladies humaines. La Revue de Médecine Interne 35:11, pages 730-741.
Crossref
Antoine Néel, Benoit Henry, Sebastien Barbarot, Agathe Masseau, François Perrin, Claire Bernier, Xavier Kyndt, Xavier Puechal, Pierre-Jean Weiller, Olivier Decaux, Jacques Ninet, Arnaud Hot, Achille Aouba, Leonardo Astudillo, Jean-Marie Berthelot, Fabrice Bonnet, Jean-Marie Brisseau, Bérangère Cador, Fabienne Closs-Prophette, Thomas Dejoie, Jean-Dominique de Korwin, Robin Dhote, Renato Fior, Bernard Grosbois, Eric Hachulla, Pierre-Yves Hatron, Henry Jardel, David Launay, Adrien Lorleac'h, Pierre Pottier, Guillaume Moulis, Jacques Serratrice, Amar Smail & Mohamed Hamidou. (2014) Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: A french multicenter study. Autoimmunity Reviews 13:10, pages 1035-1041.
Crossref
Ingo Hartig, Johann Oltmann Schroeder & Ulrich Mrowietz. (2014) Neutrophilic Urticarial Dermatosis (NUD) in Probable Adult-Onset Still Disease Responding to Anakinra. JCR Journal of Clinical Rheumatology 20:2, pages 96-98.
Crossref
François Perrin, Antoine Néel, Julie Graveleau, Anne-Lise Ruellan, Agathe Masseau & Mohamed Hamidou. (2014) Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: Drug reintroduction can be successful. La Presse Médicale 43:3, pages 319-321.
Crossref
Torsten Zuberbier & Marcus Maurer. (2014) Urticarial Vasculitis and Schnitzler Syndrome. Immunology and Allergy Clinics of North America 34:1, pages 141-147.
Crossref
Charles Anthony Dinarello. (2014) An Expanding Role for Interleukin-1 Blockade from Gout to Cancer. Molecular Medicine 20:S1, pages S43-S58.
Crossref
Heleen D Koning. (2014) Schnitzler's syndrome: lessons from 281 cases. Clinical and Translational Allergy 4:1, pages 41.
Crossref
Giuseppe TridenteGiuseppe Tridente. 2014. Adverse Events with Biomedicines. Adverse Events with Biomedicines 539 550 .
Charles A. Dinarello & Jos W.M. van der Meer. (2013) Treating inflammation by blocking interleukin-1 in humans. Seminars in Immunology 25:6, pages 469-484.
Crossref
Heleen D de Koning, Joost Schalkwijk, Johanna van der Ven-Jongekrijg, Monique Stoffels, Jos W M van der Meer & Anna Simon. (2013) Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome. Annals of the Rheumatic Diseases 72:10, pages 1634-1638.
Crossref
B. Henry, A. Néel, S. Barbarot, A. Masseau & M. Hamidou. (2013) Le syndrome de Schnitzler. La Revue de Médecine Interne 34:4, pages 224-229.
Crossref
Sinisa Savic, Laura J. Dickie, Miriam Wittmann & Michael F. McDermott. (2012) Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives. Best Practice & Research Clinical Rheumatology 26:4, pages 505-533.
Crossref
K. Krause, K. Weller, R. Stefaniak, H. Wittkowski, S. Altrichter, F. Siebenhaar, T. Zuberbier & M. Maurer. (2012) Efficacy and safety of the interleukin‐1 antagonist rilonacept in S chnitzler syndrome: an open‐label study . Allergy 67:7, pages 943-950.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.